Meal size suppression following intraperitoneal administration of GLP-1 has been shown to depend upon vagal afferent signaling (34)
Its important to note that the effectiveness and safety of these shots can vary from person to person
In addition to decreasing food intake, GLP-1 has also been shown to decrease drug intake, self-administration, conditioned place preference, and seeking in animal models (Eren-Yazicioglu et al., 2021), suggesting that GLP-1 can decrease reward responses for food rewards and beyond
doi:10.3390/mps7010017 Stone C, Harris DD, Broadwin M, et al
Professional Doctor Guidance for Addressing Microdosing Requests Healthcare providers play an essential role in educating patients about the risks and benefits of Ozempic
The membrane was washed three times, and diluted enzyme-labeled secondary antibody was added and incubated for 2 hours at room temperature